Genital psoriasis is common. In this cohort, 43.2% of psoriasis patients had genital involvement. Genital psoriasis presents differently than it does elsewhere on the body. More discussion between ...
The AMPLITUDE trial showed Zejula's efficacy in extending progression-free survival in metastatic hormone-sensitive prostate cancer with HRR gene defects. Achieving a PSA level below 0.2 in prostate ...
Arcutis Biotherapeutics has published 14 consensus statements developed by the Genital Psoriasis Wellness Consortium, a group of experts aimed at improving the understanding and management of genital ...
Standardized Patients (SP) are "Individuals who are trained to present the symptoms and signs of disease process as they present in real patients" (Barrows, 1985). Standardized patients have been ...
The Office of Standardized Patient Education (OSPE) is part of the Center for Interprofessional Education and Simulation (CIPES). The primary goal of OSPE is to enhance clinical skill acquisition and ...
Stage at presentation and survival outcomes of patients with Gleason 8 to 10 prostate cancer and low PSA. Association of baseline perineural invasion with shorter time to progression in men with ...
Genital psoriasis is common. In this cohort, 43.2% of psoriasis patients had genital involvement. Genital psoriasis presents differently than it does elsewhere on the body. More discussion between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results